FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients.

Clinical trial NCT07604792 · SUSPENDED

Trial details

NCT number: NCT07604792
Sponsor: Beijing Boren Hospital
Status: SUSPENDED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2025-09-25
Primary completion: 2025-11-07
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.